Jane Street’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-13,400
Closed -$32.8K 12988
2025
Q4
$32.8K Buy
+13,400
New +$58.2K ﹤0.01% 10627
2023
Q3
Sell
-20,000
Closed -$512K 9388
2023
Q2
$512K Sell
20,000
-13,700
-41% -$354K ﹤0.01% 6291
2023
Q1
$849K Buy
+33,700
New +$791K ﹤0.01% 5326

Other funds holding TMCI

Jane Street's TMCI Position: Q1 2026 in Review

Jane Street sold out of Treace Medical Concepts (TMCI) in Q1 2026, closing a stake of 177,008 shares — an estimated $434K sold.

Jane Street first reported a position in TMCI in Q3 2022 and held it in 12 quarters. The position peaked at $1.31M in Q1 2023. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.

  • Jane Street reported no remaining Treace Medical Concepts position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 177,008 Treace Medical Concepts shares in Q1 2026, an estimated $434K.
  • Jane Street first reported a position in Treace Medical Concepts in Q3 2022 and held it in 12 quarters.
  • Jane Street's Treace Medical Concepts position peaked at $1.31M in Q1 2023.
  • 118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.